Company News: Agena Bioscience´s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union
Agena Bioscience, a global provider of molecular genetic solutions, today announced it has been selected to participate as an innovative technology provider in the ‘Liquid biopsies and IMAging for improved cancer care’ (LIMA) project.
The LIMA project has been awarded a EUR 6.3 million Horizon 2020 European Union research grant to develop an integrated approach for personalized cancer treatment. The objective of the four-year project is to develop and validate liquid biopsy technologies in the clinical workflow and to provide more precise, dynamic tumor characterization during diagnosis and treatment.
BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it has received the WuXi AppTec Biotech Company of the Year Award at the 2017 Scrip Awards ceremony in London.